Mohammed Kashani-Sabet,Sancy A Leachman,Jennifer A Stein,Jack L Arbiser,Elizabeth G Berry,Julide T Celebi,Clara Curiel-Lewandrowski,Laura K Ferris,Jane M Grant-Kels,Douglas Grossman,Rajan P Kulkarni,Michael A Marchetti,Kelly C Nelson,David Polsky,Elizabeth V Seiverling,Susan M Swetter,Hensin Tsao,Alexandra Verdieck-Devlaeminck,Maria L Wei,Anna Bar,Edmund K Bartlett,Jean L Bolognia,Tawnya L Bowles,Kelly B Cha,Emily Y Chu,Rebecca I Hartman,Elena B Hawryluk,Risa M Jampel,Lilit Karapetyan,Meenal Kheterpal,David H Lawson,Philip D Leming,Tracey N Liebman,Michael E Ming,Debjani Sahni,Stephanie A Savory,Saba S Shaikh,Arthur J Sober,Vernon K Sondak,Natalie Spaccarelli,Richard P Usatine,Suraj Venna,John M Kirkwood

Abstract:Importance: Therapy for advanced melanoma has transformed during the past decade, but early detection and prognostic assessment of cutaneous melanoma (CM) remain paramount goals. Best practices for screening and use of pigmented lesion evaluation tools and gene expression profile (GEP) testing in CM remain to be defined. Objective: To provide consensus recommendations on optimal screening practices and prebiopsy diagnostic, postbiopsy diagnostic, and prognostic assessment of CM. Evidence review: Case scenarios were interrogated using a modified Delphi consensus method. Melanoma panelists (n = 60) were invited to vote on hypothetical scenarios via an emailed survey (n = 42), which was followed by a consensus conference (n = 51) that reviewed the literature and the rationale for survey answers. Panelists participated in a follow-up survey for final recommendations on the scenarios (n = 45). Findings: The panelists reached consensus (≥70% agreement) in supporting a risk-stratified approach to melanoma screening in clinical settings and public screening events, screening personnel recommendations (self/partner, primary care provider, general dermatologist, and pigmented lesion expert), screening intervals, and acceptable appointment wait times. Participants also reached consensus that visual and dermoscopic examination are sufficient for evaluation and follow-up of melanocytic skin lesions deemed innocuous. The panelists reached consensus on interpreting reflectance confocal microscopy and some but not all results from epidermal tape stripping, but they did not reach consensus on use of certain pigmented lesion evaluation tools, such as electrical impedance spectroscopy. Regarding GEP scores, the panelists reached consensus that a low-risk prognostic GEP score should not outweigh concerning histologic features when selecting patients to undergo sentinel lymph node biopsy but did not reach consensus on imaging recommendations in the setting of a high-risk prognostic GEP score and low-risk histology and/or negative nodal status. Conclusions and relevance: For this consensus statement, panelists reached consensus on aspects of a risk-stratified approach to melanoma screening and follow-up as well as use of visual examination and dermoscopy. These findings support a practical approach to diagnosing and evaluating CM. Panelists did not reach consensus on a clearly defined role for GEP testing in clinical decision-making, citing the need for additional studies to establish the clinical use of existing GEP assays.

Validation of the Newly Proposed World Health Organization Classification System for Conjunctival Melanocytic Intraepithelial Lesions: A Comparison with the C-MIN and PAM Classification Schemes

A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance

Immunohistochemical Profiling of Conjunctival Melanocytic Intraepithelial Lesions, Including SOX10, HMB45, Ki67, and P16

A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum

[A clinicopathological classification analysis of ocular mass lesions in 7 910 cases].

A Clinicopathological Analysis of Melanocytic Nevi: A Retrospective Series

The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?

Clinicopathological Analysis of 5146 Eyelid Tumours and Tumour-Like Lesions in an Eye Centre in South China, 2000–2018: a Retrospective Cohort Study

Evaluation of Confocal Laser Scanning Microscopy in Histological Classification and Photodynamic Therapy of Low-risk Basal Cell Carcinoma

American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma

Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: implications for systemic therapy

Conjunctival Melanoma: A Clinical Review and Update

Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67

Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel

Importance of Both Clinical and Dermoscopic Findings in Predicting High-Risk Histopathological Subtype in Facial Basal Cell Carcinomas

Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing

Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions

The use of Reflectance Confocal Microscopy to diagnose Malignant Melanoma and Lentigo Maligna in the United Kingdom: A Prospective Observational Trial at a Single Centre

Medically Uncontrolled Conjunctival Pyogenic Granulomas: Correlation Between Clinical Characteristics and Histological Findings

A clinicopathological classification analysis of ocular mass lesions in 7910 cases

Conjunctival keratoacanthoma: a clinical and histopathological case series